Search research articles
Contact Us
Filters
Showing results (71-80 of 243) with videos related to
Page
of 25
Sort By:
Cancers
|
January 11, 2022
Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort Experience
Tina Lamy, Bastien Cabarrou, David Planchard, et al.
Investigational New Drugs
|
November 14, 2016
Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitors
Pierre Loulergue, Mansouria Merad, Romain Coriat, et al.
JTO Clinical and Research Reports
|
May 2, 2022
Complete Remission After Immunotherapy-Induced Abdominal Tuberculosis in a Patient With Advanced NSCLC Treated With Pembrolizumab: A Case Report
Mariona Riudavets, Benjamin Wyplosz, Maria Rosa Ghigna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 2, 2017
LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value
Francesco Facchinetti, Maria Virginia Bluthgen, Gabrielle Tergemina-Clain, et al.
Cancer Treatment Reviews
|
January 16, 2022
How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC)
Fabrizio Tabbò, Chiara Pisano, Julien Mazieres, et al.
Virchows Archiv : an International Journal of Pathology
|
December 13, 2024
Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms
Christina Kanaan, Mohamed-Amine Bani, Michel Ducreux, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 22, 2011
Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer
Benjamin Besse, David Planchard, Anne-Sophie Veillard, et al.
Cancer Treatment Reviews
|
May 11, 2024
NTRK gene fusion testing and management in lung cancer
Matteo Repetto, Marina Chiara Garassino, Herbert H Loong, et al.
JAMA Oncology
|
June 12, 2020
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non-Small Cell Lung Cancer
Baptiste Kas, Hugues Talbot, Roberto Ferrara, et al.
Expert Review of Molecular Diagnostics
|
November 14, 2015
The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer
Kirsty Ross, Emma Pailler, Vincent Faugeroux, et al.
Page
of 25
Search research articles
Search
Showing results (71-80 of 243) with videos related to
Sort By:
Page
of 25
Cancers
|
January 11, 2022
Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort Experience
Tina Lamy, Bastien Cabarrou, David Planchard, et al.
Investigational New Drugs
|
November 14, 2016
Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitors
Pierre Loulergue, Mansouria Merad, Romain Coriat, et al.
JTO Clinical and Research Reports
|
May 2, 2022
Complete Remission After Immunotherapy-Induced Abdominal Tuberculosis in a Patient With Advanced NSCLC Treated With Pembrolizumab: A Case Report
Mariona Riudavets, Benjamin Wyplosz, Maria Rosa Ghigna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 2, 2017
LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value
Francesco Facchinetti, Maria Virginia Bluthgen, Gabrielle Tergemina-Clain, et al.
Cancer Treatment Reviews
|
January 16, 2022
How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC)
Fabrizio Tabbò, Chiara Pisano, Julien Mazieres, et al.
Virchows Archiv : an International Journal of Pathology
|
December 13, 2024
Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms
Christina Kanaan, Mohamed-Amine Bani, Michel Ducreux, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 22, 2011
Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer
Benjamin Besse, David Planchard, Anne-Sophie Veillard, et al.
Cancer Treatment Reviews
|
May 11, 2024
NTRK gene fusion testing and management in lung cancer
Matteo Repetto, Marina Chiara Garassino, Herbert H Loong, et al.
JAMA Oncology
|
June 12, 2020
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non-Small Cell Lung Cancer
Baptiste Kas, Hugues Talbot, Roberto Ferrara, et al.
Expert Review of Molecular Diagnostics
|
November 14, 2015
The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer
Kirsty Ross, Emma Pailler, Vincent Faugeroux, et al.
Page
of 25